We determined the FGFR4 Gly388Arg genotype and the mRNA expression of FGFR4 and N-cadherin in a cohort of 65 NSCLC tumors using DNA and RNA extracted from FFPE tumor samples. This evidence concerns the gene CDH2 and neoplasm.